Gene · 2115
Papers2,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Etv1/Er81 transcription factor coordinates myelination-related genes to regulate Schwann cell differentiation and myelination. | Ann Transl Med | 2022 | 36110998 | PubTator, text mining | PubMed |
| HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET. | J Exp Clin Cancer Res | 2022 | 36109787 | PubTator, text mining | PubMed |
| Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia. | Nat Commun | 2022 | 36104354 | PubTator, text mining | PubMed |
| THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours. | Cell Commun Signal | 2022 | 36076237 | PubTator, text mining | PubMed |
| Long non-coding RNAs play an important regulatory role in tumorigenesis and tumor progression through aerobic glycolysis. | Front Mol Biosci | 2022 | 36072431 | PubTator, text mining | PubMed |
| Protocol for the isolation of CD8+ tumor-infiltrating lymphocytes from human tumors and their characterization by single-cell immune profiling and multiome. | STAR Protoc | 2022 | 36065294 | PubTator, text mining | PubMed |
| Big data in basic and translational cancer research. | Nat Rev Cancer | 2022 | 36064595 | PubTator, text mining | PubMed |
| Epigenetic Application of ATAC-Seq Based on Tn5 Transposase Purification Technology. | Genet Res (Camb) | 2022 | 36062065 | PubTator, text mining | PubMed |
| Sex differences in gene regulatory networks during mid-gestational brain development. | Front Hum Neurosci | 2022 | 36061507 | PubTator, text mining | PubMed |
| Cell-type profiling in salamanders identifies innovations in vertebrate forebrain evolution. | Science | 2022 | 36048957 | PubTator, text mining | PubMed |
| Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers. | Genome Med | 2022 | 36045381 | PubTator, text mining | PubMed |
| African-specific molecular taxonomy of prostate cancer. | Nature | 2022 | 36045292 | PubTator, text mining | PubMed |
| Primary primitive neuroectodermal tumor of the cervix confirmed with molecular analysis in a pregnant woman: A case report and literature review. | Front Genet | 2022 | 36035131 | PubTator, text mining | PubMed |
| Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition. | Biomedicines | 2022 | 36009461 | PubTator, text mining | PubMed |
| Human tau mutations in cerebral organoids induce a progressive dyshomeostasis of cholesterol. | Stem Cell Reports | 2022 | 35985329 | PubTator, text mining | PubMed |
| Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation. | J Hematol Oncol | 2022 | 35978321 | PubTator, text mining | PubMed |
| Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer. | Cancer Cell Int | 2022 | 35974340 | PubTator, text mining | PubMed |
| Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors. | J Exp Clin Cancer Res | 2022 | 35971164 | PubTator, text mining | PubMed |
| Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance. | JCO Precis Oncol | 2022 | 35952322 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2115/papers?page=20